相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gene therapy: a viable therapeutic strategy for Parkinson's disease?
Alexander L. Berry et al.
JOURNAL OF NEUROLOGY (2011)
Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study
Fabrizio Stocchi et al.
ANNALS OF NEUROLOGY (2010)
Impulse Control Disorders in Parkinson Disease A Cross-Sectional Study of 3090 Patients
Daniel Weintraub et al.
ARCHIVES OF NEUROLOGY (2010)
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Paolo Barone et al.
LANCET NEUROLOGY (2010)
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Murat Emre et al.
LANCET NEUROLOGY (2010)
Randomized, Double-Blind, Multicenter Evaluation of Pramipexole Extended Release Once Daily in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2010)
Onset of Dyskinesia with Adjunct Ropinirole Prolonged-Release or Additional Levodopa in Early Parkinson's Disease
Ray L. Watts et al.
MOVEMENT DISORDERS (2010)
Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study
Karla Eggert et al.
MOVEMENT DISORDERS (2010)
The delayed-start study in Parkinson disease Can't satisfy everyone
C. Warren Olanow et al.
NEUROLOGY (2010)
Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease Report of the Quality Standards Subcommittee of the American Academy of Neurology
T. A. Zesiewicz et al.
NEUROLOGY (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Kenneth A. Follett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
ARCHIVES OF NEUROLOGY (2009)
Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily
Mikko Kuoppamaki et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland et al.
LANCET NEUROLOGY (2009)
A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
Angelo Antonini et al.
LANCET NEUROLOGY (2009)
Neuroprotection Trials in Parkinson's Disease: Systematic Review
Robert G. Hart et al.
MOVEMENT DISORDERS (2009)
Impulsive and Compulsive Behaviors in Parkinson's Disease
Andrew H. Evans et al.
MOVEMENT DISORDERS (2009)
The Priamo Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson's Disease
Paolo Barone et al.
MOVEMENT DISORDERS (2009)
A controlled trial of antidepressants in patients with Parkinson disease and depression
M. Menza et al.
NEUROLOGY (2009)
Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
C. Warren Olanow
NEUROLOGY (2009)
Disease-modification trials in Parkinson disease: Target populations, endpoints and study design
Olivier Rascol
NEUROLOGY (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Enteral Levodopa/Carbidopa infusion in advanced Parkinson disease: Long-term exposure
Dag Nyholm et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
Andrew J. Lees
CNS Neuroscience & Therapeutics (2008)
Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study
Fabrizio Stocchi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Non-dopaminergic treatments in development for Parkinson's disease
Susan H. Fox et al.
LANCET NEUROLOGY (2008)
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease:: A double-blind, randomized, placebo-controlled study
David Devos et al.
MOVEMENT DISORDERS (2008)
Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations
Robert A. Hauser et al.
MOVEMENT DISORDERS (2008)
A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study): Rationale, Design, and Baseline Characteristics
C. Warren Olanow et al.
MOVEMENT DISORDERS (2008)
Preventing and controlling dyskinesia in Parkinson's disease - A view of current knowledge and future opportunities
Peter Jenner
MOVEMENT DISORDERS (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Invited Article: Nervous system pathology in sporadic Parkinson disease
Heiko Braak et al.
NEUROLOGY (2008)
Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice
Meredith A. Fox et al.
PSYCHOPHARMACOLOGY (2008)
Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy
Susan H. Fox et al.
SEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE (2008)
Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole
Nir Giladi et al.
MOVEMENT DISORDERS (2007)
Impact of pramipexole on the onset of levodopa-related dyskinesias
Radu Constantinescu et al.
MOVEMENT DISORDERS (2007)
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome
Angelo Antonini et al.
MOVEMENT DISORDERS (2007)
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
Werner H. Poewe et al.
LANCET NEUROLOGY (2007)
Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease
R. Pahwa et al.
NEUROLOGY (2007)
Sarizotan as a treatment for dyskinesias in Parkinson's disease:: A double-blind placebo-controlled trial
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2007)
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa
Olivier Rascol et al.
MOVEMENT DISORDERS (2006)
A randomized trial of deep-brain stimulation for Parkinson's disease
Guenther Deuschl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Pergolide versus levodopa monotherapy in early Parkinson's disease patients:: The PELMOPET study
WH Oertel et al.
MOVEMENT DISORDERS (2006)
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
JJ Ferreira et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Nondopaminergic mechanisms in levodopa-induced dyskinesia
JA Brotchie
MOVEMENT DISORDERS (2005)
Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study
B Ravina et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
O Rascol et al.
LANCET (2005)
Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates
LA Smith et al.
MOVEMENT DISORDERS (2005)
Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years
MA Hely et al.
MOVEMENT DISORDERS (2005)
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
D Nyholm et al.
NEUROLOGY (2005)
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
G Van Camp et al.
LANCET (2004)
Levodopa in the treatment of Parkinson's disease: Current controversies
CW Olanow et al.
MOVEMENT DISORDERS (2004)
Movement disorder society task force report on the Hoehn and Yahr staging scale: Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2004)
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
MB Stern et al.
MOVEMENT DISORDERS (2004)
Rivastigmine for dementia associated with Parkinson's disease
M Emre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dopaminagonists and fibrotic valvular heart disease: Further considerations
O Rascol et al.
MOVEMENT DISORDERS (2004)
Parkinson's disease home diary: Further validation and implications for clinical trials
RA Hauser et al.
MOVEMENT DISORDERS (2004)
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
J Horvath et al.
MOVEMENT DISORDERS (2004)
Sleepiness in Parkinson's disease: A controlled study
MA Brodsky et al.
MOVEMENT DISORDERS (2003)
Increased daytime sleepiness in Parkinson's disease:: A questionnaire survey
B Högl et al.
MOVEMENT DISORDERS (2003)
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients
AJ Manson et al.
MOVEMENT DISORDERS (2002)
Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease
F Stocchi et al.
BRAIN (2002)
Treatment interventions for Parkinson's disease: an evidence based assessment
O Rascol et al.
LANCET (2002)
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
P Del Dotto et al.
MOVEMENT DISORDERS (2001)
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
R Holloway et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
O Rascol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms
TN Chase et al.
JOURNAL OF NEUROLOGY (2000)
分享论文
